Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03556501 · ClinicalTrials.gov registry record
Imaging Modalities for Pancreatic Collections
A clinical trial, sponsored by Northwell Health.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03556501: Clinical Trial study, sponsored by Northwell Health.
NCT03556501 is a clinical trial that was terminated before completion, run by Northwell Health. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03556501 was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of imaging data in pancreatic necrosis data for research purposes.
Primary Outcome
Pancreatic lesions will be evaluated using CT, MRI, EUS, endoscopy to assess for severeity based on amount of debris in the pancreatic lesion
Interventions
- DIAGNOSTIC_TEST Endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-10-30 |
Why NCT03556501 stopped before completion
NCT03556501 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Endoscopy is the first listed.
NCT03556501 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03556501 about?
NCT03556501 is a clinical study titled "Imaging Modalities for Pancreatic Collections". The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of imaging data in pancreatic necrosis data for research purposes.
What is the current status of trial NCT03556501?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2018-10-01. Estimated completion is 2019-10-30.
What interventions are being tested in trial NCT03556501?
The interventions under investigation include: Endoscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03556501?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI